Evidence map›Paper›PMID 40830229›Full record

ArticleEuropean journal of human genetics : EJHG2025

Neurobehavioral profile of individuals with pathogenic variants in CHD3.

Anca Ionescu, Emmanuelle Mazur-Lainé, Mélodie Proteau-Lemieux, Inga S Knoth, Keely Vachon, Kerri Whitlock, Hazel Maridith Barlanhan Biag, Nazim Rabouhi, Hendrikus J Van Heesbeen, Sébastien Jacquemont and 7 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Uncertainty, ethics, and progress in genomic medicine.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anca Ionescu *University of Montreal, Montreal, QC, Canada.
Emmanuelle Mazur-Lainé *University of Montreal, Montreal, QC, Canada.
Mélodie Proteau-LemieuxUniversity of Montreal, Montreal, QC, Canada.
Inga S KnothAzrieli Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.
Keely VachonUniversity of Alberta, Edmonton, AB, Canada.ORCID 0009-0002-1427-681X
Kerri WhitlockUniversity of Alberta, Edmonton, AB, Canada.
Hazel Maridith Barlanhan BiagMIND Institute of the University of California, Davis, CA, USA.
Nazim RabouhiAzrieli Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.
Hendrikus J Van HeesbeenAzrieli Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.
Sébastien JacquemontUniversity of Montreal, Montreal, QC, Canada.ORCID 0000-0001-6838-8767
David HesslMIND Institute of the University of California, Davis, CA, USA.ORCID 0000-0002-3460-9805
Leonard AbbedutoMIND Institute of the University of California, Davis, CA, USA.
Evdokia AnagnostouHolland Bloorview Research Center, Toronto, ON, Canada.
François BolducUniversity of Alberta, Edmonton, AB, Canada.
Randi J HagermanMIND Institute of the University of California, Davis, CA, USA.
Philippe M CampeauUniversity of Montreal, Montreal, QC, Canada. p.campeau@umontreal.ca.ORCID 0000-0001-9713-7107
Sarah LippéUniversity of Montreal, Montreal, QC, Canada. sarah.lippe@umontreal.ca.ORCID 0000-0002-4430-1644

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snijders Blok-Campeau syndrome (SNIBCPS), a neurodevelopmental disorder first described in 2018, is caused by heterozygous pathogenic variants in CHD3. Its encoded protein plays a crucial role in the development of the nervous system of embryos. While phenotypic traits have been broadly defined, i.e., global neurodevelopmental delays such as intellectual disabilities and delayed speech acquisition, and physical features such as characteristic facial features and macrocephaly, the phenotypic spectrum has not been further assessed. We present the neurobehavioral profile of 38 individuals with variants in CHD3 and compare it to the ones of autism spectrum disorder (ASD) and Fragile X syndrome (FXS) cohorts. Profound clinical deficits were found in adaptive functioning, communication skills, and sensorimotor functioning in most SNIBCPS participants. Similarities between FXS and SNIBCPS cohorts were unveiled, characterized by diminished levels of global adaptive behavior and adaptive functioning in the social and communication domains. Nevertheless, despite profound challenges in global adaptive behavior in SNIBCPS, we reveal the social domain as showing the highest adaptive levels alongside minimal emotional/behavioral issues within the sample, suggesting relative strengths inherent to SNIBCPS. This study enriches the scarce SNIBCPS literature by delineating the neurobehavioral phenotypic spectrum of SNIBCPS and by innovating comparisons with clinically akin neurodevelopmental disorders.

Indexed as

Autism Spectrum DisorderFragile X SyndromeMi-2 Nucleosome Remodeling and Deacetylase ComplexNeurodevelopmental DisordersAdolescentAdultChildChild, PreschoolDNA HelicasesFemaleHumansMaleMutationPhenotypeYoung AdultCHD3 protein, humanDNA HelicasesMi-2 Nucleosome Remodeling and Deacetylase Complex

Identifiers

PMID40830229
PMCPMC12480949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.